中證報引述相關人士:馬雲增持阿里體現看好前景 不僅「一股未賣」還在不斷增持
市場消息稱,阿里巴巴-SW(09988.HK)創始人馬雲、蔡崇信近期大幅增持阿里股票。據《中國證券報》記者從有關方面確認消息。相關人士表示,這體現對阿里巴巴前景非常看好,對公司未來發展、對管理團隊及戰略方向充滿信心。此外,這也有力迴應了前段時間馬雲拋售阿里巴巴的傳言,馬雲不僅「一股未賣」,還在不斷增持。
美國證監會網站一份13F文件顯示,蔡崇信家族基金Blue Pool增持了價值1.5億美元的阿里股票。另據媒體報道,馬雲同期也在大手筆增持阿里股票。(wl/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.